Langer-Giedion Syndrome (LGS), also known as Tricho-rhino-phalangeal syndrome type II, is a rare genetic disorder characterized by distinctive facial features, skeletal abnormalities, and multiple noncancerous bone growths called exostoses. It is primarily caused by deletions or mutations in the EXT1 gene, which plays a crucial role in bone growth and development.
The EXT1 Gene Langer-Giedion Syndrome Genetic Test is a specialized diagnostic tool designed to detect abnormalities in the EXT1 gene that are indicative of Langer-Giedion Syndrome. This test is crucial for confirming the diagnosis, allowing for appropriate management and genetic counseling for affected families. The genetic test involves analyzing the patient's DNA, extracted from a blood sample, to identify any deletions or mutations in the EXT1 gene that are associated with the syndrome.
Conducted at DNA Labs UAE, a leading facility in genetic testing and diagnostics, the EXT1 Gene Langer-Giedion Syndrome Genetic Test is performed under strict laboratory conditions by highly skilled geneticists and laboratory technicians. The test cost is 4400 AED, reflecting the specialized nature of the analysis and the expertise required to accurately interpret the results.
This genetic test is an invaluable resource for families seeking answers about Langer-Giedion Syndrome, providing them with crucial information for understanding the condition, planning for the future, and accessing appropriate treatments and support services.
The TRPS1 Gene Langer-Giedion Syndrome Genetic Test is a specific diagnostic assessment offered by DNA Labs UAE, designed to identify mutations in the TRPS1 gene, which are associated with Langer-Giedion Syndrome (LGS). LGS, also known as Tricho-rhino-phalangeal syndrome type II, is a rare genetic disorder characterized by distinctive facial features, skeletal abnormalities, and multiple exostoses (bone growths). The test is crucial for confirming a clinical diagnosis of LGS, enabling appropriate management and genetic counseling for affected individuals and their families. Conducted at DNA Labs UAE, a leading provider of genetic testing services in the region, the test is priced at 4400 AED. This test not only helps in the accurate diagnosis of the syndrome but also plays a vital role in the understanding of the genetic basis of the condition, paving the way for potential future treatments and interventions.
The FLNB Gene Larsen Syndrome Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE, designed to identify mutations in the FLNB gene, which are associated with Larsen syndrome. Larsen syndrome is a rare genetic disorder characterized by congenital abnormalities including dislocations of the hips, knees, and elbows, along with distinctive facial features and other skeletal anomalies. The test plays a crucial role in the early diagnosis and management of the syndrome, enabling healthcare providers to devise appropriate treatment and intervention strategies.
Priced at 4400 AED, the test involves collecting a DNA sample from the patient, usually through a blood draw or a cheek swab, which is then analyzed in the laboratory for the presence of mutations in the FLNB gene. The results from this test can provide valuable information for affected individuals and their families regarding the condition, its inheritance pattern, and the risk of passing it on to future generations. Conducted at DNA Labs UAE, the test is performed by experienced geneticists and laboratory technicians who ensure accuracy and confidentiality of the results.
The "LEFTY2 Gene Left-Right Axis Malformations Genetic Test" is a specialized diagnostic assessment offered by DNA Labs UAE, designed to identify mutations in the LEFTY2 gene, which are implicated in causing left-right axis malformations. These malformations can lead to a range of developmental abnormalities, affecting the heart, lungs, and other organs that are asymmetrically positioned in the body. The test is critical for early detection and management of conditions associated with these genetic anomalies.
Priced at 4400 AED, the test involves collecting a DNA sample from the patient, typically through a blood draw or cheek swab, which is then analyzed in the laboratory for genetic variations in the LEFTY2 gene. The results can provide valuable information for genetic counseling, guiding treatment options, and informing family planning decisions for those affected by or at risk of passing on left-right axis malformations. DNA Labs UAE ensures confidentiality and accuracy in the testing process, supporting patients and healthcare providers with crucial genetic insights.
The TLR5 gene plays a crucial role in the immune system by recognizing bacteria and activating immune responses. Variations in the TLR5 gene can influence an individual's susceptibility to infections, including Legionnaire's disease, a severe form of pneumonia caused by the Legionella bacteria. Understanding one's genetic predisposition to this disease can be crucial for preventive measures and early intervention.
DNA Labs UAE offers a specialized genetic test designed to analyze the TLR5 gene, providing insights into an individual's susceptibility to Legionnaire's disease. This test is particularly valuable for those with a family history of the disease or for individuals in environments where the risk of Legionella exposure is high.
The test is priced at 4400 AED and involves a simple and non-invasive procedure. By assessing the specific variations in the TLR5 gene, DNA Labs UAE can offer personalized recommendations for monitoring, prevention, and, if necessary, tailored treatment options, thereby enhancing individual health outcomes and providing peace of mind regarding Legionnaire's disease susceptibility.
The PTDSS1 gene Lenz-Majewski Hyperostotic Dwarfism genetic test is a specialized diagnostic tool available at DNA Labs UAE. This test is designed to identify mutations in the PTDSS1 gene, which are responsible for Lenz-Majewski Hyperostotic Dwarfism (LMHD). LMHD is a rare genetic disorder characterized by skeletal dysplasia, delayed intellectual development, and distinct facial features. The condition is inherited in an autosomal dominant pattern, meaning a mutation in just one copy of the gene is sufficient to cause the disorder.
DNA Labs UAE, a leading facility in genetic testing, offers this comprehensive test to individuals suspected of having LMHD or to families seeking genetic counseling. The test involves a detailed analysis of the PTDSS1 gene to detect any mutations that may lead to the disorder. It is a crucial step for accurate diagnosis and can help in managing the condition through early intervention and tailored treatment plans.
The cost of the PTDSS1 gene Lenz-Majewski Hyperostotic Dwarfism genetic test at DNA Labs UAE is 4400 AED. This investment covers the sophisticated techniques and expert analysis required to accurately identify the genetic alterations associated with LMHD. By opting for this test, patients and their families can gain valuable insights into their genetic makeup, enabling informed decisions regarding their health and future.
The BRAF Gene LEOPARD Syndrome Type 3 Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, aimed at identifying mutations in the BRAF gene, which are associated with LEOPARD Syndrome Type 3. This condition is a rare genetic disorder characterized by multiple congenital anomalies, including skin abnormalities, heart defects, and distinctive facial features. The test is crucial for individuals suspected of having the syndrome or for those with a family history of the condition, as it aids in confirming the diagnosis, guiding treatment decisions, and assessing the risk of passing the condition to offspring. The test cost is set at 4400 AED, reflecting the comprehensive analysis and expertise required to accurately identify the presence of BRAF gene mutations. DNA Labs UAE employs state-of-the-art genetic testing technologies to ensure reliable and precise results, supporting patients and healthcare providers in managing the condition effectively.
The GLE1 Gene Lethal Congenital Contracture Syndrome Type 1 Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the GLE1 gene, which are responsible for causing Lethal Congenital Contracture Syndrome Type 1 (LCCS1). LCCS1 is a severe genetic disorder characterized by congenital contractures of the limbs and fetal akinesia, leading to prenatal death or severe disability. This test is crucial for families with a history of the condition, as it helps in early diagnosis, allowing for informed decisions regarding management and care.
Performed through a detailed analysis of the individual's DNA, the test seeks to identify specific mutations in the GLE1 gene that are known to cause the syndrome. Given the complexity and the advanced technology required for such genetic testing, the cost of the test is set at 4400 AED. Conducting the test at DNA Labs UAE ensures accuracy and reliability, as the facility is equipped with state-of-the-art technology and staffed by professionals specialized in genetic diagnostics. This test is an invaluable resource for at-risk families, providing them with critical information about their genetic health and helping to guide their future medical and personal decisions.
The MYBPC1 gene plays a significant role in muscle development and function. Mutations in this gene are associated with Lethal Congenital Contracture Syndrome Type 4 (LCCS4), a severe genetic disorder characterized by multiple joint contractures, muscle weakness, and in many cases, early neonatal death. The condition is part of a group of disorders known as arthrogryposis multiplex congenita, which involves the development of joint contractures before birth.
To diagnose this condition accurately and to assist in genetic counseling, DNA Labs UAE offers a specialized genetic test targeting the MYBPC1 gene. This test is crucial for families with a history of LCCS4 or for those who have had an affected child, as it helps in understanding the risk of recurrence in future pregnancies and can guide clinical management.
The test involves analyzing the DNA for mutations in the MYBPC1 gene that are known to cause Lethal Congenital Contracture Syndrome Type 4. It is a comprehensive analysis that can confirm a diagnosis, provide valuable information for family planning, and potentially guide therapeutic interventions.
The cost of the MYBPC1 Gene Lethal Congenital Contracture Syndrome Type 4 Genetic Test at DNA Labs UAE is 4400 AED. Given the specialized nature of this test and the expertise required to interpret the results, this cost reflects both the technical aspects of genetic testing and the professional analysis to ensure accurate results. Families considering this test should also consult with a genetic counselor or specialist who can provide further insight into the implications of the test results and support throughout the diagnostic process.
The TP63 Gene Limb-Mammary Syndrome Genetic Test is a specialized diagnostic assessment offered by DNA Labs UAE, designed to identify mutations in the TP63 gene that are associated with Limb-Mammary Syndrome (LMS). This condition is a rare genetic disorder characterized by limb malformations, ectodermal dysplasia, and in some cases, mammary gland anomalies. The TP63 gene plays a critical role in the development and differentiation of tissues and organs during embryonic development, and mutations in this gene can lead to the clinical manifestations observed in LMS.
The test involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed in the laboratory for the presence of specific mutations in the TP63 gene that are known to cause Limb-Mammary Syndrome. It is a crucial tool for clinicians in diagnosing the syndrome, enabling them to provide appropriate genetic counseling to affected families, and to guide treatment and management decisions for individuals with the condition.
The cost of the TP63 Gene Limb-Mammary Syndrome Genetic Test at DNA Labs UAE is 4400 AED. This price reflects the comprehensive nature of the test, which includes not only the genetic analysis but also post-test counseling and support. DNA Labs UAE is equipped with state-of-the-art technology and staffed by experienced geneticists and counselors, ensuring high-quality testing and reliable results for patients and their families seeking answers about Limb-Mammary Syndrome.
